INS and neoplasm: In a study by Akingbesote et al., dapagliflozin reduced tumor glucose uptake and enhanced the cytotoxic effects of paclitaxel by lowering circulating insulin, ultimately prolonging overall survival in the MMTV-PyMT murine model of breast cancer [89].